Methylprednisolone Injection Clinical Trials

• Methylprednisolone Given by 24-Hour or 48-Hour Infusion versus Tirilazad for Acute Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00004759 - Active, not recruiting
  Spinal Cord Injury
  
• Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003682 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00053976 - Active, not recruiting
  Graft Versus Host Disease
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
  ClinicalTrials.gov Identifier: NCT00004482 - Active, not recruiting
  Myocarditis; Giant Cell Myocarditis
  
• Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00248534 - Recruiting
  Primary Central Nervous System Lymphoma
  
• Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
  ClinicalTrials.gov Identifier: NCT00066469 - Recruiting
  post-transplant lymphoproliferative disorder
  
• Alemtuzumab, Tacrolimus, and Methylprednisolone in Treating Acute Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00109993 - Active, not recruiting
  Breast Cancer; Endocrine Cancer; female reproductive cancer; Graft Versus Host Disease; hematopoietic and lymphoid cancer; Neuroblastoma
  
• Phase II Study of Methylprednisolone and Xylose Absorption in Children with Hypersensitivity Vasculitis Associated with Connective Tissue Disease
  ClinicalTrials.gov Identifier: NCT00004357 - Recruiting
  Vasculitis, Hypersensitivity; Connective Tissue Diseases; Dermatomyositis; Vasculitis
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
  ClinicalTrials.gov Identifier: NCT00069966 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma; anaplastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
  
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003661 - Active, not recruiting
  Leukemia; Lymphoma
  
• Avonex (Interferon-Beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-Remitting MS
  ClinicalTrials.gov Identifier: NCT00168766 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Etanercept, Mycophenolate Mofetil, Denileukin Diftitox, or Pentostatin Combined With Prednisone or Methylprednisolone in Treating Patients With Acute Graft-Versus-Host Disease Who Have Undergone a Previous Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00253656 - Recruiting
  Cancer; Graft Versus Host Disease
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• Steroid Withdrawal in Pediatric Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00023244 - Active, not recruiting
  End-Stage Renal Disease
  
• Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002471 - Active, not recruiting
  Lymphoma; Leukemia
  
• Pediatric Kidney Transplant without Calcineurin Inhibitors
  ClinicalTrials.gov Identifier: NCT00023231 - Active, not recruiting
  End-Stage Renal Disease
  
• Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
  ClinicalTrials.gov Identifier: NCT00003187 - Active, not recruiting
  Lymphoma; Leukemia
  
• Hantavirus Cardiopulmonary Syndrome
  ClinicalTrials.gov Identifier: NCT00128180 - Recruiting
  Hantaviruses
  
• High-Dose Methylprednisolone and Rituximab in High Risk B-CLL
  ClinicalTrials.gov Identifier: NCT00558181 - Recruiting
  Chronic B-Lymphocytic Leukemia
  
• Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00005641 - Active, not recruiting
  Leukemia; Multiple Myeloma
  
• A Randomized Study of IVIG Vs. IVIG With High Dose Methylprednisolone in Childhood ITP.
  ClinicalTrials.gov Identifier: NCT00376077 - Recruiting
  Immune Thrombocytopenic Purpura
  
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003270 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
  ClinicalTrials.gov Identifier: NCT00301301 - Recruiting
  Non-Hodgkins Lymphoma
  
• Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00005988 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Optic Neuritis Treatment Trial (ONTT)
  ClinicalTrials.gov Identifier: NCT00000146 - Active, not recruiting
  Multiple Sclerosis; Optic Neuritis
  
• AVONEX® Combination Trial - "ACT"
  ClinicalTrials.gov Identifier: NCT00112034 - Active, not recruiting
  Multiple Sclerosis, Relapsing-Remitting
  
• Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00005852 - Active, not recruiting
  Lymphoma; Multiple Myeloma; Leukemia
  
• Safety and Efficacy Study of Erythropoietin as Add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis
  ClinicalTrials.gov Identifier: NCT00355095 - Recruiting
  Optic Neuritis
  
• Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00241982 - Recruiting
  Rheumatoid Arthritis
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00002831 - Active, not recruiting
  Leukemia, Myeloid; Leukemia, Myeloid, Chronic
  
• Longitudinal Optic Neuritis Study (LONS)
  ClinicalTrials.gov Identifier: NCT00000147 - Active, not recruiting
  Multiple Sclerosis; Optic Neuritis
  
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
  Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
  
• Sudden Hearing Loss Multicenter Treatment Trial
  ClinicalTrials.gov Identifier: NCT00097448 - Recruiting
  Sudden Deafness
  
• Adverse Drug Reactions of Different Brands of Ceftazidime Injection
  ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
  Infection
  
• Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
  ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
  Pain
  
• Validation of Self-Reported Needle Sharing Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
  Viral Infection
  
• EPC by Intracoronary Injection in Patients With Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
  Coronary Artery Disease
  
• Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00241254 - Recruiting
  Multiple Sclerosis, Chronic Progressive
  
• A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
  Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
  
• Combination Chemotherapy in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00002835 - Active, not recruiting
  Lymphoma
  
• The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
  ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
  Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
  
• Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003278 - Active, not recruiting
  primary central nervous system lymphoma; intraocular lymphoma
  
• Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
  Type A Botulinum Toxin; Tennis Elbow
  
• Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00017654 - Active, not recruiting
  Graft Versus Host Disease; Aplastic Anemia
  
• Combination Chemotherapy and Interferon alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
  ClinicalTrials.gov Identifier: NCT00002599 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
  ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
  Myocardial Infarction; Heart Failure, Congestive
  
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
  Psoriasis
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
  ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
  Schizophrenia
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• A Single-Arm Phase II Study of Alemtuzumab in Combination With High-Dose Methylprednisolone in CLL Patients With p53 Deletion
  ClinicalTrials.gov Identifier: NCT00292760 - Not yet recruiting
  Chronic Lymphocytic Leukaemia
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
  ClinicalTrials.gov Identifier: NCT00491712 - Active, not recruiting
  Neovascular Glaucoma
  
• A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218192 - Active, not recruiting
  HCV Negative Status; HCV Risk Behavior
  
• A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
  ClinicalTrials.gov Identifier: NCT00225095 - Active, not recruiting
  Recovery Following Partial Medial Meniscectomy
  
• Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
  Colorectal Neoplasms
  
• Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00004034 - Active, not recruiting
  L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; cardiac toxicity; ...
  
• Evaluation of the Tolerability and Efficacy of Erythropoietin(EPO) Treatment in Spinal Shock: Comparative Study VS Methylprednisolone(MP)
  ClinicalTrials.gov Identifier: NCT00561067 - Not yet recruiting
  Spinal Cord Injury
  
• Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00143559 - Active, not recruiting
  Neoplasm, leukemia, myeloid; Lymphoma, Non-Hodgkin; Stem Cell Transplantation; Myelodysplastic Syndromes; Hepatic Cancer
  
• Umbilical Cord Blood Transplantation in Treating Patients With Severe Aplastic Anemia, Malignant Thymoma, or Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00003336 - Active, not recruiting
  atypical chronic myeloid leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
  Breast Cancer
  
• Vitamin K Injections for the Treatment of Painful Menstruation
  ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
  Dysmenorrhea
  
• Scleroderma: Cyclophosphamide or Transplantation (SCOT)
  ClinicalTrials.gov Identifier: NCT00114530 - Recruiting
  Scleroderma, Systemic; Sclerosis
  
• Stem Cell Transplantation for Patients with Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00152139 - Active, not recruiting
  Acute Lymphoblastic Leukemias; Acute Myelocytic Leukemia; Chronic Myeloid Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; ...
  
• Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002833 - Active, not recruiting
  Chronic Myelogenous Leukemia; Graft vs Host Disease; Philadelphia chromosome; Myeloid Leukemia; Refractory Anemia; Chronic Myelomonocytic Leukemia
  
• Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
  ClinicalTrials.gov Identifier: NCT00004645 - Active, not recruiting
  Acute Disseminated Encephalomyelitis; Devic's Syndrome; Marburg's variant of multiple sclerosis; Balo's Concentric Sclerosis; ...
  
• Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003650 - Active, not recruiting
  stage I childhood lymphoblastic lymphoma; stage II childhood lymphoblastic lymphoma; stage III childhood lymphoblastic lymphoma; ...
  
• Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
  ClinicalTrials.gov Identifier: NCT00104299 - Recruiting
  Vasculitis; Wegener's Granulomatosis
  
• Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
  ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
  Melanoma
  
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
  ClinicalTrials.gov Identifier: NCT00003662 - Active, not recruiting
  Graft Versus Host Disease; Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; ...
  
• Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00004740 - Active, not recruiting
  Tuberculosis
  
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
  ClinicalTrials.gov Identifier: NCT00003913 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; myelodysplastic and myeloproliferative diseases
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
  ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
  Carcinoid Tumor; Acromegaly
  
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00053105 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma; recurrent grade III follicular large cell lymphoma; recurrent cutaneous T-cell lymphoma; ...
  
• Patients Preference With Self-Injection: The PRISM Study
  ClinicalTrials.gov Identifier: NCT00253396 - Recruiting
  Bruises
  
• Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
  ClinicalTrials.gov Identifier: NCT00076648 - Active, not recruiting
  Hemorrhagic Shock
  
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
  Diabetic Macular Edema
  
• Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00394030 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00087776 - Active, not recruiting
  Malignant Melanoma
  
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
  ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Study of TPI 287 in Patients with Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00113724 - Active, not recruiting
  Neoplasms
  
• Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003335 - Active, not recruiting
  childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases
  
• Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
  ClinicalTrials.gov Identifier: NCT00055653 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; myelodysplastic and myeloproliferative diseases
  
• A Study to Determine the Effectiveness and Safety of Risperidone in the Prevention of Bipolar Mood Episodes
  ClinicalTrials.gov Identifier: NCT00132678 - Active, not recruiting
  Bipolar Disorder
  
• Azithromycin/Bicillin for treatment of early syphilis
  ClinicalTrials.gov Identifier: NCT00031499 - Active, not recruiting
  Syphilis
  
• Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
  ClinicalTrials.gov Identifier: NCT00002524 - Active, not recruiting
  AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related diffuse mixed cell lymphoma; ...
  
• Treating High Risk Leukemia with CD40 Ligand & IL-2 Gene Modified Tumor Vaccine.
  ClinicalTrials.gov Identifier: NCT00058799 - Active, not recruiting
  Leukemia
  
• Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
  ClinicalTrials.gov Identifier: NCT00417703 - Recruiting
  Choroidal Neovascularization
  
• Botulinum Toxin Injection for the Management of BPH
  ClinicalTrials.gov Identifier: NCT00451191 - Recruiting
  Benign Prostatic Hyperplasia
  
• Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis
  ClinicalTrials.gov Identifier: NCT00497913 - Recruiting
  Tennis Elbow
  
• Stem Cell Transplant for Children Less Then Two Years with Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00145626 - Recruiting
  Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Myelodysplasia
  
• A Phase 2 open-label clinical study using intravenous Paxceed™ to treat patients with rheumatoid arthritis
  ClinicalTrials.gov Identifier: NCT00055133 - Active, not recruiting
  Rheumatoid Arthritis
  
• ATX-101 (Sodium Deoxycholate for Injection) for the Treatment of Superficial Lipomas
  ClinicalTrials.gov Identifier: NCT00422188 - Recruiting
  Lipoma
  
• The ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention)
  ClinicalTrials.gov Identifier: NCT00069784 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Phase III Randomized, Double-Blind Study of Dexamethasone vs Dexamethasone/Methylprednisolone vs Placebo for Bronchopulmonary Dysplasia
  ClinicalTrials.gov Identifier: NCT00004785 - Completed
  Bronchopulmonary Dysplasia
  
• Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
  ClinicalTrials.gov Identifier: NCT00230035 - Recruiting
  Systemic Lupus Erythematosus